Deuda Externa, Inversión y Crecimiento en Colombia, 1970-2002.

Este trabajo examina la relación entre la deuda externa, la inversión privada y el crecimiento para Colombia en el período 1970-2002. Se utilizaron dos especificaciones, una en donde las ecuaciones de crecimiento e inversión son lineales, y otra en la cual la relación entre deuda externa y crecimiento es de tipo curva de Laffer. Estas ecuaciones fueron estimadas simultáneamente mediante mínimos cuadrados en dos estapas con variables instrumentales. Los resultados indican que en la especificación lineal, la deuda externa como proporción del PIB tiene una relación negativa con el crecimiento en la cual un incremento de 5.6 puntos en el indicador de deuda se asocia con una caída de un punto en la tasa de crecimiento del producto. Adicionalmente, se encontró una relación cuadrática en la cual la deuda externa tiene un efecto negativo a partir de un nivel de endeudamiento de 27.1 puntos del PIB. Finalmente, se halló que la inversión privada está asociada directamente con el flujo de endeudamiento privado e inversamente con el endeudamiento externo público.Deuda externa, inversión privada, crecimiento económico, hipótesis de sobreendeudamiento, curva de laffer.

Deuda externa, inversión y crecimiento en Colombia, 1970-2002

El objetivo central del trabajo es responder a la siguiente pregunta: ¿para Colombia, existe evidencia de que el nivel de endeudamiento externo influye sobre el crecimiento económico? Esta pregunta se desarrolla siguiendo los lineamientos de los principales trabajos empíricos  encontrados en la literatura económica sobre el tema. Los resultados obtenidos deben interpretarse como una aproximación preliminar al problema en la cual se detectan hechos estilizados para la economía colombiana en el período bajo estudio

Pressure Studies on a High-TcT_c Superconductor Pseudogap and Critical Temperatures

We report simultaneous hydrostatic pressure studies on the critical temperature $T_c$ and on the pseudogap temperature $T^*$ performed through resistivity measurements on an optimally doped high-$T_c$ oxide $Hg_{0.82}Re_{0.18}Ba_2Ca_2Cu_3O_{8+\delta}$. The resistivity is measured as function of the temperature for several different applied pressure below 1GPa. We find that both $T_c$ and $T^*$ increases linearly with the pressure. This result demonstrate that the well known intrinsic pressure effect on $T_c$ is also present at $T^*$ and both temperatures are originated by the same superconducting mechanism.Comment: 4 pages and 2 figures in eps, final versio

Adherence to chronic medication in older populations: application of a common protocol among three European cohorts

Purpose: The purpose of this study was to evaluate and compare medication adherence to chronic therapies in older populations across different regions in Europe. Methods: This explorative study applied a harmonized method of data extraction and analysis from pharmacy claims databases of three European countries to compare medication adherence at a cross-country level. Data were obtained for the period between January 1, 2010, and December 31, 2011. Patients (aged >= 65 years) who newly initiated to oral antidiabetics, antihyperlipidemics, or antiosteoporotics were identified and followed for over a 12-month period. Main outcome measures were medication adherence (medication possession ratio, [MPR]; implementation) and persistence on index treatment. All country-specific data sets were prepared by employing a common data input model. Outcome measures were calculated for each country and pooled using random effect models. Results: In total, 39, 186 new users were analyzed. In pooled data from the three countries, suboptimal implementation (MPR <80%) was 52.45% (95% CI: 33.43-70.79) for antihyperlipidemics, 61.35% (95% CI: 52.83-69.22) for antiosteoporotics, and 30.33% (95% CI: 25.53-35.60) for oral antidiabetics. Similarly, rates of non-persistence (discontinuation) were 55.63% (95% CI: 35.24-74.29) for antihyperlipidemics, 60.24% (95% CI: 45.35-73.46) for antiosteoporotics, and 46.80% (95% CI: 36.40-57.4) for oral antidiabetics. Conclusion: Medication adherence was suboptimal with >50% of older people non-adherent to antihyperlipidemics and antiosteoporotics in the three European cohorts. However, the degree of variability in adherence rates among the three countries was high. A harmonized method of data extraction and analysis across health-related database in Europe is useful to compare medication-taking behavior at a cross-country level

Changes in multimorbidity and polypharmacy patterns in young and adult population over a 4-year period: A 2011–2015 comparison using real-world data

The pressing problem of multimorbidity and polypharmacy is aggravated by the lack of specific care models for this population. We aimed to investigate the evolution of multimorbidity and polypharmacy patterns in a given population over a 4-year period (2011–2015). A cross-sectional, observational study among the EpiChron Cohort, including anonymized demographic, clinical and drug dispensation information of all users of the public health system ≥65 years in Aragon (Spain), was performed. An exploratory factor analysis, stratified by age and sex, using an open cohort was carried out based on the tetra-choric correlations among chronic diseases and dispensed drugs during 2011 and compared with 2015. Seven baseline patterns were identified during 2011 named as: mental health, respiratory, allergic, mechanical pain, cardiometabolic, osteometabolic, and allergic/derma. Of the epidemiological patterns identified in 2015, six were already present in 2011 but a new allergic/derma one appeared. Patterns identified in 2011 were more complex in terms of both disease and drugs. Results confirmed the existing association between age and clinical complexity. The systematic associations between diseases and drugs remain similar regarding their clinical nature over time, helping in early identification of potential interactions in multimorbid patients with a high risk of negative health outcomes due to polypharmacy

Baseline drug treatments as indicators of increased risk of COVID-19 mortality in Spain and Italy

This study aims to identify baseline medications that, as a proxy for the diseases they are dispensed for, are associated with increased risk of mortality in COVID-19 patients from two regions in Spain and Italy using real-world data. We conducted a cross-country, retrospective, observational study including 8570 individuals from both regions with confirmed SARS-CoV-2 infection between 4 March and 17 April 2020, and followed them for a minimum of 30 days to allow sufficient time for the studied event, in this case death, to occur. Baseline demographic variables and all drugs dispensed in community pharmacies three months prior to infection were extracted from the PRECOVID Study cohort (Aragon, Spain) and the Campania Region Database (Campania, Italy) and analyzed using logistic regression models. Results show that the presence at baseline of potassium-sparing agents, antipsychotics, vasodilators, high-ceiling diuretics, antithrombotic agents, vitamin B12, folic acid, and antiepileptics were systematically associated with mortality in COVID-19 patients from both countries. Treatments for chronic cardiovascular and metabolic diseases, systemic inflammation, and processes with increased risk of thrombosis as proxies for the conditions they are intended for can serve as timely indicators of an increased likelihood of mortality after the infection, and the assessment of pharmacological profiles can be an additional approach to the identification of at-risk individuals in clinical practice

Initial therapy, regimen change, and persistence in a spanish cohort of newly treated type 2 diabetes patients: A retrospective, observational study using real-world data

The World Health Organization considers the non-adherence to medication a significant issue with global impact, especially in chronic conditions such as type 2 diabetes. We aim to study antidiabetic treatment initiation, add-on, treatment switching, and medication persistence. We conducted an observational study on 4247 individuals initiating antidiabetic treatment between 2013 and 2014 in the EpiChron Cohort (Spain). We used Cox regression models to estimate the likelihood of non-persistence after a one-year follow-up, expressed as hazard ratios (HRs). Metformin was the most frequently used first-line antidiabetic (80% of cases); combination treatment was the second most common treatment in adults aged 40–79 years, while dipeptidyl peptidase-4 inhibitors were the second most common in individuals in their 80s and over, and in patients with renal disease. Individuals initiated on metformin were less likely to present addition and switching events compared with any other antidiabetic. Almost 70% of individuals initiated on monotherapy were persistent. Subjects aged 40 and over (HR 0.53–0.63), living in rural (HR 0.79) or more deprived areas (HR 0.77–0.82), or receiving polypharmacy (HR 0.84), were less likely to show discontinuation. Our findings could help identify the population at risk of discontinuation, and offer them closer monitoring for proper integrated management to improve prognosis and health outcomes

A Theory for High-TcT_c Superconductors Considering Inhomogeneous Charge Distribution

We propose a general theory for the critical $T_c$ and pseudogap $T^*$ temperature dependence on the doping concentration for high-$T_c$ oxides, taking into account the charge inhomogeneities in the $CuO_2$ planes. The well measured experimental inhomogeneous charge density in a given compound is assumed to produce a spatial distribution of local $\rho(r)$. These differences in the local charge concentration is assumed to yield insulator and metallic regions, possibly in a stripe morphology. In the metallic region, the inhomogeneous charge density yields also spatial distributions of superconducting critical temperatures $T_c(r)$ and zero temperature gap $\Delta_0(r)$. For a given sample, the measured onset of vanishing gap temperature is identified as the pseudogap temperature, that is, $T^*$, which is the maximum of all $T_c(r)$. Below $T^*$, due to the distribution of $T_c(r)$'s, there are some superconducting regions surrounded by insulator or metallic medium. The transition to a superconducting state corresponds to the percolation threshold among the superconducting regions with different $T_c(r)$'s. To model the charge inhomogeneities we use a double branched Poisson-Gaussian distribution. To make definite calculations and compare with the experimental results, we derive phase diagrams for the BSCO, LSCO and YBCO families, with a mean field theory for superconductivity using an extended Hubbard Hamiltonian. We show also that this novel approach provides new insights on several experimental features of high-$T_c$ oxides.Comment: 7 pages, 5 eps figures, corrected typo

Artistas sobre outras Obras

Entre a pele da pintura e a pele do pintor, existe uma continuidade interrompida pelo encerramento da peça, em que o autor se despede e abre caminho aos novos participantes. Estes são seres políticos, pois são público, são relação. As quinze propostas de abordagem à obra de outros tantos artistas que aqui são apresentadas, neste número 35 da Revista Estúdio, transportam um desejo interior de uma expansão para os vivos, para novas relações, novos trânsitos, no círculo aberto das artesinfo:eu-repo/semantics/publishedVersio

Erratum to: 36th International Symposium on Intensive Care and Emergency Medicine

[This corrects the article DOI: 10.1186/s13054-016-1208-6.]